View Older Stories View More Recent Stories

Aug 6, 2025 04:04PM Soleno Therapeutics reports early commercial traction for VYKAT XR
Aug 6, 2025 04:15AM Rhythm Pharmaceuticals (RYTM) PT Raised to $135 at Citizens JMP
Jul 11, 2025 07:26AM Stifel Reiterates Buy Rating on Soleno Therapeutics Inc. (SLNO)
Jul 10, 2025 04:13PM Soleno Therapeutics Inc. (SLNO) PT Raised to $121 at Baird
Jul 10, 2025 09:08AM Soleno Therapeutics prices $200 million stock offering at $85 per share
Jul 10, 2025 07:24AM Stifel Reiterates Buy Rating on Soleno Therapeutics Inc. (SLNO)
Jul 10, 2025 06:01AM Soleno Therapeutics reports preliminary Q2 revenue of $31-33 million
Jul 8, 2025 07:05AM Stifel Raises PT to $115 on Soleno Therapeutics Inc. (SLNO)
Jul 7, 2025 04:27PM Soleno Therapeutics Inc. (SLNO) PT Raised to $115 at Stifel
Jul 7, 2025 09:41AM Piper Sandler on Soleno Therapeutics Inc. (SLNO): 'VYKAT XR PWS Launch Is Destined for Success'
Jun 25, 2025 08:02AM Soleno Therapeutics (SLNO) Highlights New Data on VYKAT(TM) XR
Jun 23, 2025 05:31AM TD Cowen Starts Soleno Therapeutics Inc. (SLNO) at Buy
Jun 17, 2025 08:07AM Piper Sandler 'Remains Bullish' on Soleno Therapeutics Inc. (SLNO)
May 27, 2025 09:52AM Stifel Reiterates Buy Rating on Soleno Therapeutics Inc. (SLNO)
May 22, 2025 05:35PM Soleno Therapeutics (SLNO) announces EMA validation of MAA
May 22, 2025 07:32AM Cantor Fitzgerald Reiterates Overweight Rating on Soleno Therapeutics Inc. (SLNO)
May 20, 2025 04:20PM Soleno Therapeutics (SLNO) Announces Data Presentation Showing that Resumption of Treatment with VYKAT
May 20, 2025 08:30AM Piper Sandler: 'We Remain Bullish and View Soleno Therapeutics (SLNO) As a Key Name to Own'
May 8, 2025 06:12AM Oppenheimer Reiterates Outperform Rating on Soleno Therapeutics Inc. (SLNO)
May 7, 2025 04:22PM Soleno Therapeutics, Inc. (SLNO) Misses Q1 EPS by 6c
May 7, 2025 04:02PM Soleno Therapeutics (SLNO) Provides Update on U.S. Launch of VYKAT XR
Apr 24, 2025 08:22AM Soleno Therapeutics Inc. (SLNO) PT Raised to $145 at Piper Sandler
Apr 14, 2025 07:02AM Soleno Therapeutics (SLNO) Announces VYKAT XR Launch
Apr 11, 2025 09:44AM Piper Sandler: 'What Biotech Names to Own in Market Volatility'
Apr 2, 2025 07:04AM Smid cap biotech investors must stop chasing binary events says Cantor Fitzgerald
Apr 1, 2025 07:11AM Piper Sandler 'Remains Bullish' on Soleno Therapeutics Inc. (SLNO) Following VYKAT XR Approval
Mar 31, 2025 06:40AM Soleno Therapeutics Inc. (SLNO) PT Raised to $100 at H.C. Wainwright
Mar 28, 2025 07:26AM Soleno Therapeutics Inc. (SLNO) PT Raised to $108 at Stifel
Mar 28, 2025 06:59AM Soleno Therapeutics Inc. (SLNO) PT Raised to $81 at Guggenheim
Mar 27, 2025 08:17AM Piper Sandler on Soleno Therapeutics Inc. (SLNO): 'VYKAT XR Approved With Spot Clean Label & Lucrative Pricing'
Mar 27, 2025 07:53AM Stifel Reiterates Buy Rating on Soleno Therapeutics Inc. (SLNO)
Mar 27, 2025 07:40AM Soleno Therapeutics Inc. (SLNO) PT Raised to $105 at Oppenheimer
Mar 27, 2025 07:37AM Soleno Therapeutics Inc. (SLNO) PT Raised to $123 at Cantor Fitzgerald
Mar 27, 2025 05:12AM Stifel Reiterates Buy Rating on Soleno Therapeutics Inc. (SLNO)
Mar 27, 2025 04:59AM Soleno Therapeutics Inc. (SLNO) PT Raised to $102 at Baird
Mar 26, 2025 05:17PM Soleno Therapeutics (SLNO) announced FDA approval for Prader-Willi Syndrome treatment
Mar 26, 2025 04:04PM Soleno Therapeutics (SLNO) Halted, News Pending
Mar 26, 2025 04:52AM Increasing unusual call option volume: SLNO ATEC COPX CRMD PRCH EU BJ SMG BTU
Mar 12, 2025 09:07AM Stifel Reiterates Buy Rating on Soleno Therapeutics Inc. (SLNO)
Mar 5, 2025 06:45AM Stifel Resumes Soleno Therapeutics Inc. (SLNO) at Buy
Mar 3, 2025 08:49AM Cantor Fitzgerald Reiterates Overweight Rating on Soleno Therapeutics Inc. (SLNO)
Dec 19, 2024 09:42AM Stifel Names Top Picks in Biotechnology 2025 Outlook Note
Dec 17, 2024 04:06PM Soleno Therapeutics (SLNO) Enters Into $200M Debt Financing with Oxford Finance LLC
Dec 2, 2024 06:58AM Baird Reiterates Outperform Rating on Soleno Therapeutics Inc. (SLNO)
Dec 2, 2024 06:43AM H.C. Wainwright Reiterates Buy Rating on Soleno Therapeutics Inc. (SLNO)
Nov 29, 2024 11:46AM Baird Reiterates Outperform Rating on Soleno Therapeutics Inc. (SLNO)
Nov 26, 2024 08:31AM Soleno Therapeutics (SLNO) Announces FDA Extension of Review Period for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome
Nov 6, 2024 04:26PM Soleno Therapeutics, Inc. (SLNO) Misses Q3 EPS by 122c
Oct 28, 2024 06:42AM Soleno Therapeutics Inc. (SLNO) PT Raised to $73 at Oppenheimer
Oct 8, 2024 02:57PM Laidlaw Reiterates Buy Rating on Soleno Therapeutics Inc. (SLNO)
View More Recent Stories View Older Stories